Ikashi Screener(USA)

PROCTER & GAMBLE Co

PG · CIK 0000080424 · NYSE · Consumer Staples (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics)

Overview — PROCTER & GAMBLE Co

Revenue (TTM)
$87.92B
Net Income (TTM)
$16.12B
Total Assets
$133.13B
Total Debt
$21.90B

Pros

  • Strong return on equity (TTM)
  • Strong free cash flow generation
  • Operating cash flow comfortably exceeds reported net income

Cons

    Chart

    No price data yet — run npm run ingest:prices in apps/api.

    Revenue & Net Income

    RevenueNet Income
    025B50B75B100B2017201820192020202120222023202420252026TTM

    Peers

    Sector: Consumer Staples. Sector is derived from SEC's SIC code, not GICS. Click a column to sort.

    CompanyMarket Cap ▼Revenue (TTM) Net Income (TTM) Net Margin ROE Debt/Equity
    KO COCA COLA CO—$51.05B$14.76B28.9%37.3%—
    PG PROCTER & GAMBLE Co—$87.92B$16.12B18.3%29.1%0.40
    PEP PEPSICO INC—$98.24B$10.97B11.2%48.8%—

    Quarterly results

    Line itemDec 22Mar 23Sep 23Dec 23Mar 24Sep 24Dec 24Mar 25Sep 25Dec 25Mar 26Sep 26
    Revenue$20.77B$20.07B$21.87B$21.44B$20.20B$21.74B$21.88B$19.78B$22.39B$22.21B$21.23B$23.28B
    Net Income$3.96B$3.42B$4.56B$3.49B$3.78B$3.99B$4.66B$3.79B$4.78B$4.33B$3.95B$4.76B
    Operating Cash Flow——$4.90B——$4.30B——$5.41B——$5.77B

    Profit & Loss

    Line item2017201820192020202120222023202420252026TTM
    Revenue$65.06B$66.83B$67.68B$70.95B$76.12B$80.19B$82.01B$84.04B$84.28B$87.03B$87.92B
    Net Income$15.41B$9.86B$3.97B$13.10B$14.35B$14.79B$14.74B$14.97B$16.07B$16.14B$16.12B

    Balance Sheet

    Line item2017201820192020202120222023202420252026TTM
    Total Assets————$119.31B$117.21B$120.83B$122.37B$125.23B$126.52B$133.13B
    Total Liabilities————$72.65B$70.35B$73.76B$71.81B$72.95B$72.21B$77.80B
    Total Equity————$46.65B$46.85B$47.06B$50.56B$52.28B$54.31B$55.34B
    Total Debt————$23.10B$22.85B$24.38B$25.27B$25.00B$22.84B$21.90B
    Shares Outstanding————2,427,424,8742,389,553,8832,357,306,1872,354,050,9872,342,371,4882,324,433,0602,317,783,143

    Cash Flow

    Line item2017201820192020202120222023202420252026TTM
    Operating Cash Flow$12.75B$14.87B$15.24B$17.40B$18.37B$16.72B$16.85B$19.85B$17.82B$19.56B$19.91B
    Capex$3.38B$3.72B$3.35B$3.07B$2.79B$3.16B$3.06B$3.32B$3.77B$4.41B$4.58B

    Ratios

    Profitability

    Ratio2017201820192020202120222023202420252026TTM
    Net margin23.7%14.8%5.9%18.5%18.9%18.4%18.0%17.8%19.1%18.5%18.3%
    Return on equity————30.8%31.6%31.3%29.6%30.7%29.7%29.1%
    Return on assets————12.0%12.6%12.2%12.2%12.8%12.8%12.1%
    Return on capital employed (ROCE)————20.9%21.2%21.3%20.9%22.9%22.5%22.5%
    Debt / Equity————0.500.490.520.500.480.420.40
    FCF margin14.4%16.7%17.6%20.2%20.5%16.9%16.8%19.7%16.7%17.4%17.4%

    Working capital

    Ratio2017201820192020202120222023202420252026TTM
    Debtor days————23d23d24d27d27d25d27d
    Inventory days————59d60d60d63d67d69d70d
    Payable days————135d129d125d137d135d137d141d
    Cash conversion cycle————-53d-45d-40d-48d-41d-43d-43d
    Working capital days————-48d-52d-58d-39d-46d-52d-52d

    Investors

    US filings have no equivalent to India's Promoter/FII/DII shareholding-pattern disclosure. Shown below are the closest real US sources: Form 4 insider transactions and Form 13F institutional holders (matched by issuer name, not CUSIP — a few companies, especially ones that changed their legal name, may be incomplete).

    Institutional Holders

    No data yet — run npm run ingest:institutions in apps/api.

    Insider Trades

    PersonRelationshipDateTypeSharesPrice
    Jejurikar ShaileshChairman, President and CEO10/23/2026Option exercise35,000$78.52
    Jejurikar ShaileshChairman, President and CEO10/23/2026Sale35,000$163.09
    Purushothaman BalajiChief Human Resources Officer10/23/2026Sale4,181$160.71
    Gama PaulCEO- Health Care10/23/2026Sale4,331$161.27
    Subramaniam RajeshDirector10/13/2026Grant/Award1,438—
    Portman Robert JonesDirector10/13/2026Grant/Award1,438—
    McEvoy AshleyDirector10/13/2026Grant/Award1,438—
    McCarthy Christine MDirector10/13/2026Grant/Award1,438—
    Kempczinski Christopher JDirector10/13/2026Grant/Award1,438—
    JIMENEZ JOSEPHDirector10/13/2026Grant/Award1,438—
    Chang AmyDirector10/13/2026Grant/Award1,438—
    Bonini SheilaDirector10/13/2026Grant/Award1,438—
    Biggs M. BrettDirector10/13/2026Grant/Award1,438—
    ARNOLD CRAIGDirector10/13/2026Grant/Award1,438—
    Allen Bertrand MarcDirector10/13/2026Grant/Award1,438—
    Schulten AndreChief Financial Officer10/5/2026Sale3,914$145.34
    Gama PaulCEO- Health Care10/5/2026Sale2,225$145.34
    Whaley Susan StreetChief Legal Officer & Secy10/5/2026Sale2,369$145.34
    Whaley Susan StreetChief Legal Officer & Secy10/1/2026Grant/Award6,110—
    Schulten AndreChief Financial Officer10/1/2026Grant/Award6,557—
    Gama PaulCEO- Health Care10/1/2026Grant/Award12,517—

    Documents